Syprine (Valeant Pharmaceuticals North America LLC)


Welcome to the PulseAid listing for the Syprine drug offered from Valeant Pharmaceuticals North America LLC. This Metal Chelating Activity [MoA],Metal Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America LLC
NON-PROPRIETARY NAME: trientine hydrochloride
SUBSTANCE NAME: TRIENTINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Metal Chelating Activity [MoA],Metal Chelator [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1985-11-08
END MARKETING DATE: 0000-00-00


Syprine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSyprine from Valeant Pharmaceuticals North America LLC
LABELER NAME: Valeant Pharmaceuticals North America LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 1985-11-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0187-2120_1573b87f-4dab-4a45-9cbb-9cbf9d8c7321
PRODUCT NDC: 0187-2120
APPLICATION NUMBER: NDA019194

Other TRIENTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Valeant Pharmaceuticals North America LLCSyprine